86 related articles for article (PubMed ID: 7974715)
1. Evidence that rapamycin inhibits interleukin-12-induced proliferation of activated T lymphocytes.
Bertagnolli MM; Yang L; Herrmann SH; Kirkman RL
Transplantation; 1994 Nov; 58(10):1091-6. PubMed ID: 7974715
[TBL] [Abstract][Full Text] [Related]
2. IL-12 augments antigen-dependent proliferation of activated T lymphocytes.
Bertagnolli MM; Lin BY; Young D; Herrmann SH
J Immunol; 1992 Dec; 149(12):3778-83. PubMed ID: 1360994
[TBL] [Abstract][Full Text] [Related]
3. Characterization of HTLV-I in vivo infected T cell clones. IL-2-independent growth of nontransformed T cells.
Höllsberg P; Wucherpfennig KW; Ausubel LJ; Calvo V; Bierer BE; Hafler DA
J Immunol; 1992 May; 148(10):3256-63. PubMed ID: 1374452
[TBL] [Abstract][Full Text] [Related]
4. Autocrine and paracrine regulation of human T cell IL-10 production.
Cohen SB; Parry SL; Feldmann M; Foxwell B
J Immunol; 1997 Jun; 158(12):5596-602. PubMed ID: 9190906
[TBL] [Abstract][Full Text] [Related]
5. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
[TBL] [Abstract][Full Text] [Related]
6. Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression.
Chae DW; Nosaka Y; Strom TB; Maslinski W
J Immunol; 1996 Oct; 157(7):2813-9. PubMed ID: 8816384
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
Powell JD; Lerner CG; Schwartz RH
J Immunol; 1999 Mar; 162(5):2775-84. PubMed ID: 10072524
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
9. Macrophage inflammatory protein-1 alpha rapidly modulates its receptors and inhibits the anti-CD3 mAb-mediated proliferation of T lymphocytes.
Zhou Z; Kim YJ; Pollok K; Hurtado J; Lee JK; Broxmeyer HE; Kwon BS
J Immunol; 1993 Oct; 151(8):4333-41. PubMed ID: 8409405
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of T and B lymphocyte proliferation by rapamycin.
Kay JE; Kromwel L; Doe SE; Denyer M
Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
[TBL] [Abstract][Full Text] [Related]
11. Regulation of human T cell proliferation by IL-7.
Armitage RJ; Namen AE; Sassenfeld HM; Grabstein KH
J Immunol; 1990 Feb; 144(3):938-41. PubMed ID: 2295821
[TBL] [Abstract][Full Text] [Related]
12. Effect of transforming growth factor-beta on early and late activation events in human T cells.
Ahuja SS; Paliogianni F; Yamada H; Balow JE; Boumpas DT
J Immunol; 1993 Apr; 150(8 Pt 1):3109-18. PubMed ID: 8468460
[TBL] [Abstract][Full Text] [Related]
13. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
[TBL] [Abstract][Full Text] [Related]
14. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
15. Bortezomib can suppress activation of rapamycin-resistant memory T cells without affecting regulatory T-cell viability in non-human primates.
Kim JS; Lee JI; Shin JY; Kim SY; Shin JS; Lim JH; Cho HS; Yoon IH; Kim KH; Kim SJ; Park CG
Transplantation; 2009 Dec; 88(12):1349-59. PubMed ID: 20029331
[TBL] [Abstract][Full Text] [Related]
16. Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling.
Conrad DM; Hanniman EA; Watson CL; Mader JS; Hoskin DW
J Cell Biochem; 2004 May; 92(2):387-99. PubMed ID: 15108363
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lymphoproliferative responses by SK&F 105685, a novel anti-arthritic agent.
Kaplan JM; Badger AM; Ruggieri EV; Olivera DL; Newman-Tarr T; Bugelski PJ
J Clin Lab Immunol; 1991 Dec; 36(4):49-58. PubMed ID: 1668843
[TBL] [Abstract][Full Text] [Related]
18. Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways.
Butler JJ; Mader JS; Watson CL; Zhang H; Blay J; Hoskin DW
J Cell Biochem; 2003 Aug; 89(5):975-91. PubMed ID: 12874832
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
Makrigiannis AP; Hoskin DW
J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
[TBL] [Abstract][Full Text] [Related]
20. CD28 co-stimulation regulates the effect of transforming growth factor-beta1 on the proliferation of naïve CD4+ T cells.
Sung JL; Lin JT; Gorham JD
Int Immunopharmacol; 2003 Feb; 3(2):233-45. PubMed ID: 12586604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
